Apyx Medical (APYX) Sr. VP granted 63,392 stock options at $4.65 strike

Rhea-AI Filing Summary

Apyx Medical Corp reported that Sr. V.P. of Operations Moshe Citronowicz received a grant of stock options. The award covers 63,392 options to buy common stock at an exercise price of $4.65 per share, expiring on June 11, 2036.

According to the disclosure, these options were granted at no cost and will vest ratably over 36 months, becoming fully vested and exercisable on the third anniversary of the grant date. Following this grant, the filing shows beneficial ownership of 63,392 derivative securities directly held as options.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider CITRONOWICZ MOSHE

Role Sr. V.P. of Operations

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Option to Buy)	63,392	$0.00	--

Holdings After Transaction: Stock Option (Option to Buy) — 63,392 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 63,392 options Exercise price: $4.65 per share Expiration date: June 11, 2036 +2 more

5 metrics

Options granted 63,392 options Grant to Sr. V.P. of Operations on June 11, 2026

Exercise price $4.65 per share Stock option strike price for Apyx common stock

Expiration date June 11, 2036 Option term for granted stock options

Vesting period 36 months Options vest ratably and fully vest on third anniversary

Shares underlying options 63,392 shares Underlying common stock linked to granted options

Key Terms

Stock Option (Option to Buy), grant/award acquisition, exercise price, vest ratably, +1 more

5 terms

Stock Option (Option to Buy) financial

"security_title: "Stock Option (Option to Buy)""

grant/award acquisition financial

"transaction_action: "grant/award acquisition""

exercise price financial

"conversion_or_exercise_price": "4.6500""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest ratably financial

"stock option which shall vest ratably over a thirty six (36) month period"

fully exercisable financial

"shall become fully vested and fully exercisable on the third anniversary"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CITRONOWICZ MOSHE

(Last) (First) (Middle)

C/O APYX MEDICAL CORPORATION

5115 ULMERTON ROAD

(Street)

CLEARWATER FLORIDA 33760

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Apyx Medical Corp [ APYX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. V.P. of Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Option to Buy)	$4.65	06/11/2026		A		63,392		(1)	06/11/2036	Common Stock	63,392	$0	63,392	D

Explanation of Responses:

1. Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

	/s/ Moshe Citronowicz	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)